Mid-course sample size modification in clinical trials based on the observed treatment effect.
about
Data-driven analysis strategies for proportion studies in adaptive group sequential test designs.Choosing inclusion criteria that minimize the time and cost of clinical trialsSample size re-assessment leading to a raised sample size does not inflate type I error rate under mild conditions.Sample size re-estimation for adaptive sequential design in clinical trials.Clinical Trial Adaptation by Matching Evidence in Complementary Patient Sub-groups of Auxiliary Blinding Questionnaire ResponsesAdaptive choice of patient subgroup for comparing two treatments.Research designs for proof-of-concept chronic pain clinical trials: IMMPACT recommendationsSample Size Reassessment and Hypothesis Testing in Adaptive Survival TrialsStopping clinical trials by design.Sample size re-estimation in an on-going NIH-sponsored clinical trial: the secondary prevention of small subcortical strokes experience.Adaptive statistical analysis following sample size modification based on interim review of effect size.Adaptive design of confirmatory trials: Advances and challenges.Adaptive seamless designs: selection and prospective testing of hypotheses.A review and re-interpretation of a group-sequential approach to sample size re-estimation in two-stage trials.Two-stage designs in bioequivalence trials.Twenty-five years of confirmatory adaptive designs: opportunities and pitfalls.Meta-analyses and adaptive group sequential designs in the clinical development process.Cell therapy for heart disease: Trial sequential analyses of two Cochrane reviews.A Bayesian adaptive blinded sample size adjustment method for risk differences.Optimal flexible sample size design with robust power.Testing multiple primary endpoints in clinical trials with sample size adaptation.Sample size adjustment based on promising interim results and its application in confirmatory clinical trials.Adaptive sample size modification in clinical trials: start small then ask for more?Adaptive extensions of a two-stage group sequential procedure for testing primary and secondary endpoints (II): sample size re-estimation.Many-to-one comparison after sample size reestimation for trials with multiple treatment arms and treatment selection.Flexible design clinical trial methodology in regulatory applications.An adaptive design to bridge the gap between Phase 2b/3 microbicide effectiveness trials and evidence required for licensure.Adaptive clinical trial designs with pre-specified rules for modifying the sample size: understanding efficient types of adaptation.Comments on the FDA draft guidance on adaptive designs.An objective re-evaluation of adaptive sample size re-estimation: commentary on 'Twenty-five years of confirmatory adaptive designs'.An evaluation of increasing sample size based on conditional power.Comments on 'Adaptive increase in sample size when interim results are promising: a practical guide with examples'.Adaptive increase in sample size when interim results are promising: a practical guide with examples.Stepwise two-stage sample size adaptation.An adaptive confirmatory trial with interim treatment selection: practical experiences and unbalanced randomization.Group sequential and adaptive designs: a novel, promising tool for nursing research.Point and interval estimation of primary and secondary parameters in a two-stage adaptive clinical trial.Adaptive Budgets in Clinical TrialsA Practical Comparison of Group-Sequential and Adaptive Designs
P2860
Q30883035-7357B44E-CCF0-442F-9817-AFE36ED6C1E7Q34367570-F84BBF8D-08E9-4EF3-A817-1530E2D9C397Q34840765-9829F48D-F36C-4B3E-971D-049BE81D9499Q34875047-2387B65A-DD96-4900-8CDD-462343267FEFQ35687969-B663C96E-F9C5-442F-AC73-C4D4CE330880Q35751782-243D66EA-AEBF-4770-8971-4A2E1AE8A423Q35846608-B9796EA0-C96A-41DD-BCE9-56B5AA987E9DQ35919624-D1587560-2C50-4F15-8EFA-2B483A76E4D7Q35936444-91A855A3-F2CF-4471-A051-EC9B4159B915Q36129605-C1C614CF-168F-418F-BFF5-187D11D8DA5FQ36196222-B4FB8B21-3E06-47DA-8765-1B6560DA172DQ36264856-0F94ED57-18AE-4404-BF77-B173E99D192BQ37008670-EF4CE929-CC85-4449-BDCA-9ACEF8D74093Q38201406-2621BC92-192E-415A-8B5E-CF76E4B3B7AAQ38325667-CCEA1334-4D86-4BDF-B7D3-2CE034F91673Q38380750-5899E97A-B9BA-43D9-B057-D72BE44114BCQ38473067-48FDA924-1614-445B-AACC-407DFA195FACQ38714410-2EC49077-89F0-43ED-87E5-7D36D87C693FQ38960346-BD56E432-A148-4C49-9BE4-E325341B8773Q39901774-B765D0B5-CDCA-4C35-BC83-2B8ACE53615BQ40274973-FEB76986-3596-4DE9-8FC7-3DB6D57954C5Q40714213-A8C92C78-B7F5-473E-BE03-547D65CF6546Q40739745-B3593E2A-4873-4453-AF32-A4776A486286Q43663115-EA60E4D2-43BE-4C0E-9D17-C6C19523DEC8Q43832289-2C687495-506E-4871-9C37-A2D40C8C8BEBQ43869804-F887449C-F8A1-4E09-85EC-6671FD20FD9AQ44016003-C6253E14-6903-4685-93AC-9434CBEAF7D4Q44385353-E1D1D845-DAE3-4569-9B8C-66D40EFBA2A9Q45089987-3B54BD00-7FFA-4BCE-8A24-5C90306998ACQ45292536-884A0453-5E35-4A9C-8492-E3BB5FA286F1Q47237179-97662797-5F26-44C4-A11E-6915C070162BQ47342510-40B3D793-D71A-4822-923B-A5CB6D1F7D17Q47342519-C2D1BD8D-9C58-4B08-839F-3148BA0DD21FQ47434459-D14EF390-11F3-425E-BDF0-6EA4F5FE7ACEQ48146479-6DE948F1-92D1-47D6-BE47-936D9CC2530FQ51575552-8238874B-4809-4E6A-81C7-C3BD88F9309FQ51891392-8D6CF0A6-1F94-46DA-9578-130B85BF3C90Q57305770-663B9F7B-8D69-467F-8645-46E9D35C7EEFQ57430771-2B61CB36-BEE8-4E64-B5D7-52D90435F09A
P2860
Mid-course sample size modification in clinical trials based on the observed treatment effect.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Mid-course sample size modific ...... the observed treatment effect.
@en
Mid-course sample size modific ...... the observed treatment effect.
@nl
type
label
Mid-course sample size modific ...... the observed treatment effect.
@en
Mid-course sample size modific ...... the observed treatment effect.
@nl
prefLabel
Mid-course sample size modific ...... the observed treatment effect.
@en
Mid-course sample size modific ...... the observed treatment effect.
@nl
P356
P1476
Mid-course sample size modific ...... the observed treatment effect.
@en
P2093
Bruce W Turnbull
Christopher Jennison
P304
P356
10.1002/SIM.1457
P407
P577
2003-03-01T00:00:00Z